CoChat

Failure to ubiquitinate c-Met leads to hyperactivation of mTOR signaling in a mouse model of autosomal dominant polycystic kidney disease

Open access

The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is a common inherited disorder that is caused by mutations at two loci, polycystin 1 (PKD1) and polycystin 2 (PKD2). It is characterized by the formation of multiple cysts in the kidneys that can lead to chronic renal failure. Previous studies have suggested a role for hyperactivation of mammalian target of rapamycin (mTOR) in cystogenesis, but the etiology of mTOR hyperactivation has not been fully elucidated. In this report we have shown that mTOR is hyperactivated in Pkd1-null mouse cells due to failure of the HGF receptor c-Met to be properly ubiquitinated and subsequently degraded after stimulation by HGF. In Pkd1-null cells, Casitas B-lineage lymphoma (c-Cbl), an E3-ubiquitin ligase for c-Met, was sequestered in the Golgi apparatus with α₃β₁ integrin, resulting in the inability to ubiquitinate c-Met. Treatment of mouse Pkd1-null cystic kidneys in organ culture with a c-Met pharmacological inhibitor resulted in inhibition of mTOR activity and blocked cystogenesis in this mouse model of ADPKD. We therefore suggest that blockade of c-Met is a potential novel therapeutic approach to the treatment of ADPKD.

Overview

Integrity signals

Registry

Crossref · 10.1172/jci41531

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 5

  1. Takayama, 1997, Lab Invest., 77, 131
  2. Lanoix, 1996, Oncogene., 13, 1153
  3. Ehara, 1994, Am J Pathol., 144, 612
  4. Carone, 1993, Lab Invest., 68, 413
  5. Girod, 1980, C R Seances Acad Sci D., 290, 711

Cited by

See all 72

Metadata

Authors
Qin, S., Taglienti, M., Nauli, S. M., Contrino, L., Takakura, A., Zhou, J., & Kreidberg, J. A.
Affiliations
  • Boston Children's Hospital (US)
  • Brigham and Women's Hospital (US)
Venue
Journal of Clinical Investigation
Published
2010-10-01
Volume
120
Issue
10
Pages
3617-3628
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2055349890
Cited by
70
References
67
Citations by year
2026: 2 · 2025: 6 · 2024: 3 · 2023: 4 · 2022: 3 · 2021: 3 · 2020: 5 · 2019: 3 · 2018: 4 · 2017: 5 · 2016: 1 · 2015: 5 · 2014: 7 · 2013: 5 · 2012: 9
FWCI
3.42
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Chapman University Digital Commons (Chapman University) (submittedVersion)
Funders
  • American Heart Association
  • PKD Foundation
  • National Institutes of Health (DK51050)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK50118-01, DK 40703, P50DK074030, DK 51050, R01DK050118, DK074030, R37DK051050, R01DK051050, R01DK040703)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
  • Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
Keywords
autosomal dominant polycystic kidney disease, c-Met, mTOR signaling, ubiquitination, polycystin-1, polycystin-2, c-Cbl, E3 ubiquitin ligase, HGF receptor, alpha3beta1 integrin, Golgi apparatus, cyst formation, c-Met inhibitor, therapeutic target
MeSH terms
Animals, Cell Line, Cilia, Disease Models, Animal, Glycosylation, Golgi Apparatus, Morphogenesis, Signal Transduction, Polycystic Kidney, Autosomal Dominant, Protein Serine-Threonine Kinases, Proto-Oncogene Proteins c-met, Integrin alpha3beta1, Intracellular Signaling Peptides and Proteins, TRPP Cation Channels, Proto-Oncogene Proteins c-cbl, Mice, Ubiquitination, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.